Impurity testing of ranitidine products: US FDA update

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2019年 / 1779卷 / 1期
关键词：
D O I：
10.1007/s40278-019-71265-z
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1 / 1
相关论文
共 50 条
  • [41] FDA update: 1996
    Oldham, RK
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 1996, 11 (01) : 1 - 2
  • [42] FDA Oncology Update
    不详
    AMERICAN HEALTH AND DRUG BENEFITS, 2019, 12 (04): : 198 - 200
  • [43] An evaluation of platelets, pheresis products submitted to the FDA for quality control testing
    Poindexter, BJ
    Shafer, BC
    Mondoro, TH
    Vostal, JG
    TRANSFUSION, 1999, 39 (10) : 122S - 122S
  • [44] CIMETIDINE, RANITIDINE AND FAMOTIDINE - A THERAPEUTIC UPDATE
    SIMON, B
    MULLER, P
    DAMMANN, HG
    INNERE MEDIZIN, 1984, 11 (02) : 81 - 84
  • [45] UPDATE ON RANITIDINE SIDE-EFFECTS
    BAUMAN, JH
    HOSPITAL FORMULARY, 1984, 19 (03): : 251 - 251
  • [46] Effects of the FDA's sodium reduction strategy in the US market for chip products
    Staudigel, Matthias
    Anders, Sven
    JOURNAL OF ECONOMIC BEHAVIOR & ORGANIZATION, 2020, 173 : 216 - 238
  • [47] Several products marketed as dietary supplements have been recalled by the US FDA
    Reactions Weekly, 2010, 1321 (1) : 3 - 3
  • [48] US FDA warns manufacturers about illegal steroid-containing products
    Reactions Weekly, 2006, 1093 (1) : 2 - 2
  • [49] HIV testing at visits to US emergency departments: 2021 update
    Clay, Carson
    Kuglen, Brian Christopher
    Bennett, Christopher Lee
    SEXUALLY TRANSMITTED INFECTIONS, 2024, 100 (03) : 193 - 194
  • [50] Response to the US FDA LeadCare Testing Systems Recall and CDC Health Alert
    Mason, Jacquelyn
    Ortiz, Denise
    Pappas, Siobhan
    Quigley, Susan
    Yendell, Stephanie
    Ettinger, Adrienne S.
    JOURNAL OF PUBLIC HEALTH MANAGEMENT AND PRACTICE, 2019, 25 : S91 - S97
12345